Balance Sheet Johnson & Johnson

Equities

JNJ

US4781601046

Pharmaceuticals

Market Closed - Nyse Other stock markets 04:00:02 2025-12-05 pm EST			5-day change	1st Jan Change
201.93 ^USD	-0.27%		-2.41%	+39.63%

Dec. 07	Eli Lilly, Pfizer Secure Inclusion in Chinese Private Health Insurance Catalog	MT
Dec. 06	Johnson & Johnson Announces Updated Results For CARVYKTI In Relapsed Or Refractory Multiple Myeloma	CI

a36c9526404bb3c2.r8Rh-JkVTSRztwF2HAs-7D0e1ZxwjHi6xjPrXpwAEK8.2JVYl8FwfVwY1FgsSn9_32lpgP5JyBfrpGHabvZJdt_avAeV0G8hYiWaRA

Published financial data: JOHNSON & JOHNSON

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Revenues	82.58B	93.78B	94.94B	85.16B	88.82B
Total Revenues	82.58B	93.78B	94.94B	85.16B	88.82B
Cost of Goods Sold, Total	28.33B	29.76B	30.99B	26.24B	27.04B
Gross Profit	54.26B	64.02B	63.95B	58.92B	61.78B
Selling General & Admin Expenses, Total	22.08B	24.06B	23.6B	20.17B	21.95B
R&D Expenses	12.16B	14.71B	14.6B	15.08B	17.23B
Other Operating Expenses, Total	34.24B	38.77B	38.21B	35.25B	39.18B
Operating Income	20.01B	25.25B	25.75B	23.66B	22.6B
Interest Expense, Total	-201M	-183M	-276M	-772M	-755M
Interest And Investment Income	111M	53M	490M	1.26B	1.33B
Net Interest Expenses	-90M	-130M	214M	489M	577M
Currency Exchange Gains (Loss)	-209M	-236M	-328M	-366M	-214M
Other Non Operating Income (Expenses)	469M	991M	1.83B	1.66B	1.48B
EBT, Excl. Unusual Items	20.18B	25.87B	27.46B	25.45B	24.45B
Restructuring Charges	-447M	-452M	-521M	-798M	-269M
Merger & Related Restructuring Charges	-	-117M	-300M	-200M	-1.2B
Gain (Loss) On Sale Of Investments	972M	1.09B	-700M	-600M	-300M
Gain (Loss) On Sale Of Assets	111M	617M	380M	117M	226M
Asset Writedown	-190M	-936M	-1.22B	-1.3B	-405M
In Process R&D Expenses	-181M	-900M	-783M	-313M	-211M
Legal Settlements	-5.1B	-2.3B	-900M	-6.9B	-5.5B
Other Unusual Items	1.15B	-100M	-1.7B	-400M	-100M
EBT, Incl. Unusual Items	16.5B	22.78B	21.72B	15.06B	16.69B
Income Tax Expense	1.78B	1.9B	3.78B	1.74B	2.62B
Earnings From Continuing Operations	14.71B	20.88B	17.94B	13.33B	14.07B
Earnings Of Discontinued Operations	-	-	-	21.83B	-
Net Income to Company	14.71B	20.88B	17.94B	35.15B	14.07B
Net Income - (IS)	14.71B	20.88B	17.94B	35.15B	14.07B
Net Income to Common Incl Extra Items	14.71B	20.88B	17.94B	35.15B	14.07B
Net Income to Common Excl. Extra Items	14.71B	20.88B	17.94B	13.33B	14.07B
Per Share Items
Net EPS - Basic	5.59	7.93	6.83	13.88	5.84
Basic EPS - Continuing Operations	5.59	7.93	6.83	5.26	5.84
Basic Weighted Average Shares Outstanding	2.63B	2.63B	2.63B	2.53B	2.41B
Net EPS - Diluted	5.51	7.81	6.73	13.72	5.79
Diluted EPS - Continuing Operations	5.51	7.81	6.73	5.2	5.79
Diluted Weighted Average Shares Outstanding	2.67B	2.67B	2.66B	2.56B	2.43B
Normalized Basic EPS	4.79	6.14	6.54	6.28	6.35
Normalized Diluted EPS	4.72	6.05	6.44	6.21	6.29
Dividend Per Share	3.98	4.19	4.45	4.7	4.91
Payout Ratio	71.23	52.84	65.11	33.48	84.05
American Depositary Receipts Ratio (ADR)	0.07	0.07	0.07	0.07	0.07
Supplemental Items
EBITDA	27.24B	32.64B	32.72B	30.77B	29.94B
EBITA	24.71B	29.95B	30.05B	28.16B	27.1B
EBIT	20.01B	25.25B	25.75B	23.66B	22.6B
EBITDAR	27.54B	32.94B	33.02B	30.97B	30.14B
Effective Tax Rate - (Ratio)	10.81	8.33	17.42	11.53	15.71
Current Domestic Taxes	1.03B	1.52B	2.38B	2.7B	2.2B
Current Foreign Taxes	1.9B	2.45B	3.07B	3.09B	2.6B
Total Current Taxes	2.92B	3.98B	5.45B	5.8B	4.8B
Deferred Domestic Taxes	-76M	583M	-2.08B	-3.44B	-2.54B
Deferred Foreign Taxes	-1.06B	-2.66B	418M	-619M	356M
Total Deferred Taxes	-1.14B	-2.08B	-1.66B	-4.06B	-2.18B
Normalized Net Income	12.62B	16.17B	17.17B	15.91B	15.28B
Interest Capitalized	63M	49M	49M	70M	79M
Non-Cash Pension Expense	-590M	-798M	-1.37B	-1.57B	-1.17B
Supplemental Operating Expense Items
Advertising Expense	2.1B	2.7B	2.1B	500M	600M
Selling and Marketing Expenses	2.1B	2.7B	2.1B	500M	600M
Research And Development Expense From Footnotes	12.34B	15.61B	15.39B	15.4B	17.44B
Net Rental Expense, Total	300M	300M	300M	200M	200M
Imputed Operating Lease Interest Expense	19.48M	15.66M	20.6M	37.86M	39.09M
Imputed Operating Lease Depreciation	281M	284M	279M	162M	161M
Stock-Based Comp., Other (Total)	1B	1.14B	1.14B	1.16B	1.18B
Total Stock-Based Compensation	1B	1.14B	1.14B	1.16B	1.18B

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	13.98B	14.49B	14.13B	21.86B	24.1B
Short Term Investments	11.2B	17.12B	9.39B	1.07B	417M
Trading Asset Securities, Total	240M	-	-	-	-
Total Cash And Short Term Investments	25.42B	31.61B	23.52B	22.93B	24.52B
Accounts Receivable, Total	13.58B	15.28B	16.16B	14.87B	14.84B
Total Receivables	13.58B	15.28B	16.16B	14.87B	14.84B
Inventory	9.34B	10.39B	12.48B	11.18B	12.44B
Prepaid Expenses	1.99B	3.7B	3.13B	4.51B	4.08B
Other Current Assets, Total	898M	-	-	-	-
Total Current Assets	51.24B	60.98B	55.29B	53.5B	55.89B
Gross Property Plant And Equipment	47.8B	48.58B	50.35B	48.78B	49.87B
Accumulated Depreciation	-28.04B	-28.72B	-29.45B	-27.88B	-28.25B
Net Property Plant And Equipment	19.77B	19.86B	20.9B	20.9B	21.62B
Long-term Investments	2.19B	2.38B	1.27B	9.07B	5.52B
Goodwill	36.39B	35.25B	45.23B	36.56B	44.2B
Other Intangibles, Total	53.4B	46.39B	48.32B	34.18B	37.62B
Deferred Tax Assets Long-Term	8.53B	10.22B	9.12B	9.28B	10.46B
Other Long-Term Assets, Total	3.37B	6.93B	7.23B	4.08B	4.79B
Total Assets	175B	182B	187B	168B	180B
Liabilities
Accounts Payable, Total	9.5B	11.06B	11.7B	9.63B	10.31B
Accrued Expenses, Total	28.96B	29.29B	29.2B	30.21B	30.26B
Short-term Borrowings	832M	1.64B	11.22B	1.98B	4.23B
Current Portion of Long-Term Debt	1.8B	2.13B	1.55B	1.47B	1.75B
Current Portion of Leases	-	-	-	-	-
Current Income Taxes Payable	1.39B	1.11B	2.13B	2.99B	3.77B
Total Current Liabilities	42.49B	45.23B	55.8B	46.28B	50.32B
Long-Term Debt	32.64B	29.98B	26.89B	25.88B	30.65B
Long-Term Leases	1.1B	1B	1.3B	1.1B	1.2B
Pension & Other Post Retirement Benefits	10.77B	8.9B	6.77B	7.15B	7.26B
Deferred Tax Liability Non Current	7.21B	7.49B	6.37B	3.19B	2.45B
Other Non Current Liabilities	17.4B	15.4B	13.44B	15.18B	16.74B
Total Liabilities	112B	108B	111B	98.78B	109B
Common Stock, Total	3.12B	3.12B	3.12B	3.12B	3.12B
Retained Earnings	114B	123B	128B	154B	156B
Treasury Stock	-38.49B	-39.1B	-41.69B	-75.66B	-75.68B
Comprehensive Income and Other	-15.24B	-13.06B	-12.97B	-12.53B	-11.74B
Total Common Equity	63.28B	74.02B	76.8B	68.77B	71.49B
Total Equity	63.28B	74.02B	76.8B	68.77B	71.49B
Total Liabilities And Equity	175B	182B	187B	168B	180B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	2.63B	2.63B	2.6B	2.41B	2.41B
ECS Total Common Shares Outstanding	2.63B	2.63B	2.61B	2.41B	2.41B
Book Value / Share	24.04	28.16	29.39	28.57	29.7
Tangible Book Value	-26.52B	-7.62B	-16.75B	-1.96B	-10.33B
Tangible Book Value Per Share	-10.07	-2.9	-6.41	-0.81	-4.29
Total Debt	36.37B	34.75B	40.96B	30.43B	37.83B
Net Debt	9.46B	3.14B	17.44B	7.5B	13.31B
Debt Equivalent of Unfunded Proj. Benefit Obligation	5.1B	-348M	-1.88B	-1.86B	-3.08B
Debt Equivalent Oper. Leases	2.4B	2.4B	2.4B	1.6B	1.6B
Account Code - Inventory Valuation	5	5	5	5	5
Inventories - Raw Materials, Total	1.41B	1.59B	2.07B	2.36B	2.34B
Inventories - Work In Process, Total	2.04B	2.29B	1.7B	1.95B	2.82B
Inventories - Finished Goods, Total	5.89B	6.51B	8.71B	6.87B	7.29B
Land - (BS)	882M	884M	859M	795M	718M
Buildings, Total	12.5B	12.88B	12.99B	12.38B	12.32B
Machinery, Total	29.1B	29.77B	30.43B	28.98B	29.44B
Full Time Employees	134K	142K	153K	132K	138K
Accumulated Allowance for Doubtful Accounts (Supple)	293M	230M	203M	166M	167M

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	14.71B	20.88B	17.94B	35.15B	14.07B
Depreciation & Amortization - CF	2.53B	2.69B	2.67B	2.6B	2.84B
Amortization of Goodwill and Intangible Assets - (CF)	4.7B	4.7B	4.3B	4.5B	4.5B
Depreciation & Amortization, Total	7.23B	7.39B	6.97B	7.1B	7.34B
(Gain) Loss From Sale Of Asset	-111M	-617M	-380M	-21.1B	-226M
Asset Writedown & Restructuring Costs	233M	989M	1.22B	1.78B	2.25B
Provision for Credit Losses	63M	-48M	-	-	-
Stock-Based Compensation (CF)	1B	1.14B	1.14B	1.16B	1.18B
Provision and Write-off of Bad Debts	-	-	-17M	-	11M
Net Cash From Discontinued Operations	-	-	-	383M	-
Other Operating Activities, Total	-2.29B	-2.08B	-1.66B	-4.19B	-2.18B
Change In Accounts Receivable	774M	-2.4B	-1.29B	-624M	-406M
Change In Inventories	-265M	-1.25B	-2.53B	-1.32B	-1.13B
Change In Accounts Payable	5.14B	2.44B	1.1B	2.35B	1.62B
Change in Other Net Operating Assets	-2.96B	-3.02B	-1.29B	2.11B	1.75B
Cash from Operations	23.54B	23.41B	21.19B	22.79B	24.27B
Capital Expenditure	-3.35B	-3.65B	-4.01B	-5.01B	-4.42B
Sale of Property, Plant, and Equipment	305M	711M	543M	358M	675M
Cash Acquisitions	-7.32B	-60M	-17.65B	-	-15.15B
Divestitures	-	-	-	-	-
Sale (Purchase) of Intangible assets	-	-	-	-	-1.78B
Investment in Marketable and Equity Securities, Total	-8.95B	-5.39B	9.22B	8.48B	736M
Other Investing Activities, Total	-1.51B	-294M	-478M	-2.95B	1.34B
Cash from Investing	-20.82B	-8.68B	-12.37B	878M	-18.6B
Short Term Debt Issued, Total	3.39B	2B	16.13B	13.74B	15.28B
Long-Term Debt Issued, Total	7.43B	5M	2M	-	6.66B
Total Debt Issued	10.82B	2B	16.14B	13.74B	21.94B
Short Term Debt Repaid, Total	-2.66B	-1.19B	-6.55B	-22.97B	-9.46B
Long-Term Debt Repaid, Total	-1.06B	-1.8B	-2.13B	-1.55B	-1.45B
Total Debt Repaid	-3.73B	-2.99B	-8.68B	-24.52B	-10.92B
Issuance of Common Stock	1.11B	1.04B	1.33B	1.09B	838M
Repurchase of Common Stock	-3.22B	-3.46B	-6.04B	-5.05B	-2.43B
Common Dividends Paid	-10.48B	-11.03B	-11.68B	-11.77B	-11.82B
Common & Preferred Stock Dividends Paid	-10.48B	-11.03B	-11.68B	-11.77B	-11.82B
Other Financing Activities, Total	-627M	395M	65M	10.69B	-736M
Cash from Financing	-6.12B	-14.05B	-8.87B	-15.82B	-3.13B
Foreign Exchange Rate Adjustments	89M	-178M	-312M	-112M	-289M
Net Change in Cash	-3.32B	502M	-360M	7.73B	2.25B
Supplemental Items
Cash Interest Paid	841M	941M	933M	1.77B	1.91B
Cash Income Tax Paid (Refund)	4.62B	4.77B	5.22B	8.57B	6.71B
Levered Free Cash Flow	21.86B	18.82B	19.19B	19.79B	16.67B
Unlevered Free Cash Flow	21.98B	18.93B	19.36B	20.27B	17.14B
Change In Net Working Capital	-4.58B	1.72B	833M	-2.23B	-704M
Net Debt Issued / Repaid	7.1B	-990M	7.45B	-10.78B	11.02B

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	7.52	8.84	8.71	8.33	8.13
Return on Total Capital	13.32	15.14	14.21	13.65	13.55
Return On Equity %	23.97	30.41	23.79	18.31	20.06
Return on Common Equity	23.97	30.41	23.79	18.31	20.06
Margin Analysis
Gross Profit Margin %	65.7	68.27	67.36	69.18	69.56
SG&A Margin	26.74	25.66	24.86	23.68	24.71
EBITDA Margin %	32.99	34.8	34.46	36.13	33.71
EBITA Margin %	29.93	31.93	31.65	33.07	30.51
EBIT Margin %	24.23	26.92	27.12	27.79	25.45
Income From Continuing Operations Margin %	17.82	22.26	18.9	15.65	15.84
Net Income Margin %	17.82	22.26	18.9	41.28	15.84
Net Avail. For Common Margin %	17.82	22.26	18.9	15.65	15.84
Normalized Net Income Margin	15.28	17.24	18.08	18.68	17.2
Levered Free Cash Flow Margin	26.46	20.07	20.21	23.24	18.76
Unlevered Free Cash Flow Margin	26.62	20.19	20.39	23.8	19.29
Asset Turnover
Asset Turnover	0.5	0.53	0.51	0.48	0.51
Fixed Assets Turnover	4.3	4.73	4.66	4.27	4.18
Receivables Turnover (Average Receivables)	5.89	6.5	6.04	5.89	5.98
Inventory Turnover (Average Inventory)	3.09	3.02	2.71	2.45	2.29
Short Term Liquidity
Current Ratio	1.21	1.35	0.99	1.16	1.11
Quick Ratio	0.92	1.04	0.71	0.82	0.78
Operating Cash Flow to Current Liabilities	0.55	0.52	0.38	0.49	0.48
Days Sales Outstanding (Average Receivables)	63.02	56.01	60.27	61.79	60.89
Days Outstanding Inventory (Average Inventory)	120.26	120.69	134.32	148.75	159.04
Average Days Payable Outstanding	116.86	121.5	125.19	130.83	128.26
Cash Conversion Cycle (Average Days)	66.42	55.2	69.4	79.71	91.67
Long Term Solvency
Total Debt/Equity	57.47	46.95	53.33	44.25	52.92
Total Debt / Total Capital	36.5	31.95	34.78	30.68	34.61
LT Debt/Equity	53.31	41.86	36.7	39.23	44.55
Long-Term Debt / Total Capital	33.86	28.49	23.94	27.2	29.13
Total Liabilities / Total Assets	63.82	59.33	59.01	58.96	60.31
EBIT / Interest Expense	99.57	137.96	93.29	30.65	29.94
EBITDA / Interest Expense	137.04	179.98	119.63	40.11	39.92
(EBITDA - Capex) / Interest Expense	120.39	160.03	105.1	33.62	34.06
Total Debt / EBITDA	1.32	1.06	1.24	0.98	1.26
Net Debt / EBITDA	0.34	0.1	0.53	0.24	0.44
Total Debt / (EBITDA - Capex)	1.5	1.19	1.41	1.17	1.47
Net Debt / (EBITDA - Capex)	0.39	0.11	0.6	0.29	0.52
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	0.64	13.55	1.25	6.46	4.3
Gross Profit, 1 Yr. Growth %	-0.45	18.21	0.05	6.36	4.52
EBITDA, 1 Yr. Growth %	-2.62	18.49	0.54	7.92	-3.32
EBITA, 1 Yr. Growth %	-2.97	19.72	0.66	7.99	-4.45
EBIT, 1 Yr. Growth %	-4.56	24.28	2.37	6.69	-5.29
Earnings From Cont. Operations, 1 Yr. Growth %	-2.68	41.89	-14.07	-18.6	5.55
Net Income, 1 Yr. Growth %	-2.68	41.89	-14.07	95.94	-59.99
Normalized Net Income, 1 Yr. Growth %	-6.69	27.84	3.97	6.7	-5.07
Diluted EPS Before Extra, 1 Yr. Growth %	-2.13	41.74	-13.83	-15.31	11.35
Accounts Receivable, 1 Yr. Growth %	-6.25	12.57	5.74	5.94	-0.21
Inventory, 1 Yr. Growth %	3.59	11.16	20.18	8.89	11.3
Net Property, Plant and Equip., 1 Yr. Growth %	5.94	0.49	5.24	10.09	3.45
Total Assets, 1 Yr. Growth %	10.88	4.07	2.94	-10.58	7.49
Tangible Book Value, 1 Yr. Growth %	21.58	-71.28	119.99	-186.38	427.21
Common Equity, 1 Yr. Growth %	6.4	16.98	3.76	-10.46	3.95
Cash From Operations, 1 Yr. Growth %	0.51	-0.54	-9.47	7.54	6.47
Capital Expenditures, 1 Yr. Growth %	-4.32	9.11	9.78	25.04	-2.62
Levered Free Cash Flow, 1 Yr. Growth %	-11.23	-13.69	2.28	31.12	-16.31
Unlevered Free Cash Flow, 1 Yr. Growth %	-11.43	-13.67	2.58	32.8	-15.98
Dividend Per Share, 1 Yr. Growth %	6.13	5.28	6.21	5.62	4.47
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	0.61	6.9	7.22	4	5.38
Gross Profit, 2 Yr. CAGR %	-0.21	8.38	8.67	3.18	5.61
EBITDA, 2 Yr. CAGR %	-1.54	7.44	9.08	4.44	2.48
EBITA, 2 Yr. CAGR %	-1.7	7.81	9.7	4.57	1.94
EBIT, 2 Yr. CAGR %	-2.78	8.97	12.71	4.78	0.94
Earnings From Cont. Operations, 2 Yr. CAGR %	-1.92	17.51	10.42	-13.48	-7.3
Net Income, 2 Yr. CAGR %	-1.92	17.51	10.42	29.76	-11.46
Normalized Net Income, 2 Yr. CAGR %	1.96	22.91	26.93	10.99	6.5
Diluted EPS Before Extra, 2 Yr. CAGR %	-0.9	17.78	10.52	-11.64	-2.89
Accounts Receivable, 2 Yr. CAGR %	-1.87	2.73	9.1	-1.35	2.82
Inventory, 2 Yr. CAGR %	4.24	7.31	15.58	3.75	10.09
Net Property, Plant and Equip., 2 Yr. CAGR %	7.72	3.18	2.84	2.57	6.72
Total Assets, 2 Yr. CAGR %	6.93	7.42	3.51	-4.05	-1.96
Tangible Book Value, 2 Yr. CAGR %	20.34	-40.91	-20.52	-49.28	113.4
Common Equity, 2 Yr. CAGR %	2.91	11.57	10.17	-3.61	-3.52
Cash From Operations, 2 Yr. CAGR %	2.96	-0.01	-5.11	-1.33	7
Capital Expenditures, 2 Yr. CAGR %	-4.5	2.18	9.44	17.16	5.05
Levered Free Cash Flow, 2 Yr. CAGR %	12.57	-12.9	-6.13	12.02	5.08
Unlevered Free Cash Flow, 2 Yr. CAGR %	10.89	-12.98	-5.98	12.97	5.96
Dividend Per Share, 2 Yr. CAGR %	6.03	5.7	5.74	5.91	5.04
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	2.61	4.75	4.98	1.03	4.1
Gross Profit, 3 Yr. CAGR %	2.08	5.52	5.47	2.85	3.74
EBITDA, 3 Yr. CAGR %	3.55	5.11	4.99	3.82	2.01
EBITA, 3 Yr. CAGR %	4.12	5.4	5.26	4.1	1.71
EBIT, 3 Yr. CAGR %	1.93	6.04	6.59	5.3	1.59
Earnings From Cont. Operations, 3 Yr. CAGR %	124.52	10.92	5.87	-3.25	-7.55
Net Income, 3 Yr. CAGR %	124.52	10.92	5.87	33.68	-12.33
Normalized Net Income, 3 Yr. CAGR %	4.13	10.04	17.05	14.3	5.77
Diluted EPS Before Extra, 3 Yr. CAGR %	127.17	11.66	6.13	-1.91	-4.56
Accounts Receivable, 3 Yr. CAGR %	0.21	2.73	3.72	3.09	-0.97
Inventory, 3 Yr. CAGR %	2.16	6.5	11.44	6.17	6.21
Net Property, Plant and Equip., 3 Yr. CAGR %	5.14	5.25	3.86	1.87	2.86
Total Assets, 3 Yr. CAGR %	3.6	5.97	5.91	-1.42	-0.35
Tangible Book Value, 3 Yr. CAGR %	2.02	-25.36	-8.42	-58.04	10.69
Common Equity, 3 Yr. CAGR %	1.7	7.4	8.9	2.82	-1.15
Cash From Operations, 3 Yr. CAGR %	3.78	1.78	-3.27	-1.07	1.2
Capital Expenditures, 3 Yr. CAGR %	0.69	-0.16	4.65	14.41	6.6
Levered Free Cash Flow, 3 Yr. CAGR %	6.87	2.95	-8.2	-3.13	1.86
Unlevered Free Cash Flow, 3 Yr. CAGR %	5.94	1.93	-8.17	-2.54	2.56
Dividend Per Share, 3 Yr. CAGR %	6.23	5.78	5.87	5.7	5.43
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	3.34	5.46	4.43	0.86	1.6
Gross Profit, 5 Yr. CAGR %	2.22	5.03	4.63	1.57	2.54
EBITDA, 5 Yr. CAGR %	4.26	5.54	5.92	1.83	1.15
EBITA, 5 Yr. CAGR %	4.78	6.01	6.53	1.95	1.02
EBIT, 5 Yr. CAGR %	1.73	3.59	6.38	2.25	1.23
Earnings From Cont. Operations, 5 Yr. CAGR %	-0.92	4.77	69.04	-2.72	-1.43
Net Income, 5 Yr. CAGR %	-0.92	4.77	69.04	18.11	-1.43
Normalized Net Income, 5 Yr. CAGR %	2.03	5.24	8.97	5.56	7.38
Diluted EPS Before Extra, 5 Yr. CAGR %	0.11	5.66	70.29	-1.51	0.56
Accounts Receivable, 5 Yr. CAGR %	4.81	5.49	3.68	1.08	0.49
Inventory, 5 Yr. CAGR %	3.02	4.99	7.33	5.39	6.65
Net Property, Plant and Equip., 5 Yr. CAGR %	4.44	4.53	4.21	4.17	2.99
Total Assets, 5 Yr. CAGR %	5.56	5.21	3.56	1.84	2.69
Tangible Book Value, 5 Yr. CAGR %	2.22	-18.16	-7.68	-36.05	-13.89
Common Equity, 5 Yr. CAGR %	-2.32	1	5.01	2.85	3.75
Cash From Operations, 5 Yr. CAGR %	3.76	4.52	0.13	0.53	0.72
Capital Expenditures, 5 Yr. CAGR %	-0.68	2.51	4.1	6.44	4.81
Levered Free Cash Flow, 5 Yr. CAGR %	11.88	6.48	1.39	2.79	-7.64
Unlevered Free Cash Flow, 5 Yr. CAGR %	11.39	5.92	0.92	2.55	-7.27
Dividend Per Share, 5 Yr. CAGR %	6.17	5.87	6.03	5.83	5.54